Possible involvement of iron-induced oxidative insults in neurodegeneration

Neuroscience Letters

Volumn 588, Issue 1, 2015, Pages 29-35

  Asano, Takeshi ^a,b   Koike, Masato ^c   Sakata, Shin ichi ^a   Takeda, Yukiko ^a,b,d   Nakagawa, Tomoko ^a,d   Hatano, Taku ^e   Ohashi, Satoshi ^e   Funayama, Manabu ^e   Yoshimi, Kenji ^e   Asanuma, Masato ^f   Toyokuni, Shinya ^g   Mochizuki, Hideki ^a,e   Uchiyama, Yasuo ^c   Hattori, Nobutaka ^e   Iwai, Kazuhiro ^a,b,d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Iron; Iron regulatory protein; Mitochondria; Oxidative stress; Parkin; Parkinson's disease

Indexed keywords

4 HYDROXYNONENAL; MITOCHONDRIAL PROTEIN; TOLONIUM CHLORIDE; IRON; IRON REGULATORY PROTEIN 2; PARKIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GEL MOBILITY SHIFT ASSAY; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; IRON OVERLOAD; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY CONTROL; SOUTHERN BLOTTING; ANIMAL; BRAIN; CROSS BREEDING; GENETICS; HEK293 CELL LINE; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; SUBSTANTIA NIGRA; TRANSGENIC MOUSE;

ANIMALS; BRAIN; CROSSES, GENETIC; DOPAMINERGIC NEURONS; HEK293 CELLS; HELA CELLS; HUMANS; IRON; IRON REGULATORY PROTEIN 2; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOCHONDRIA; MOTOR ACTIVITY; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; SUBSTANTIA NIGRA; UBIQUITIN-PROTEIN LIGASES;

EID: 84937118633     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.12.052     Document Type: Article

References (21)

1. Ashizuka M., Fukuda T., Nakamura T., Shirasuna K., Iwai K., Izumi H., Kohno K., Kuwano M., Uchiumi T. Novel translational control through an iron-responsive element by interaction of multifunctional protein YB-1 and IRP2. Mol. Cell Biol. 2002, 22:6375-6383.
2. Crichton R.R., Dexter D.T., Ward R.J. Brain iron metabolism and its perturbation in neurological diseases. J. Neural. Transm. 2011, 118:301-314.
3. Dickson D.W., Braak H., Duda J.E., Duyckaerts C., Gasser T., Halliday G.M., Hardy J., Leverenz J.B., Del Tredici K., Wszolek Z.K., Litvan I. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 2009, 8:1150-1157.
4. Forss-Petter S., Danielson P.E., Catsicas S., Battenberg E., Price J., Nerenberg M., Sutcliffe J.G. Transgenic mice expressing β-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 1990, 5:187-197.
5. Herrup K., Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?. Nat. Rev. Neurosci. 2007, 8:368-378.
6. Iwai K., Klausner R.D., Rouault T.A. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 1995, 14:5350-5357.
7. Koike M., Shibata M., Tadakoshi M., Gotoh K., Komatsu M., Waguri S., Kawahara N., Kuida K., Nagata S., Kominami E., Tanaka K., Uchiyama Y. Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury. Am. J. Pathol. 2008, 172:454-469.
8. Matsuda N., Sato S., Shiba K., Okatsu K., Saisho K., Gautier C.A., Sou Y.S., Saiki S., Kawajiri S., Sato F., Kimura M., Komatsu M., Hattori N., Tanaka K. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J.Cell Biol. 2010, 189:211-221.
9. Meyron-Holtz E.G., Ghosh M.C., Iwai K., LaVaute T., Brazzolotto X., Berger U.V., Land W., Ollivierre-Wilson H., Grinberg A., Love P., Rouault T.A. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 2004, 23:386-395.
10. Moroishi T., Nishiyama M., Takeda Y., Iwai K., Nakayama K.I. The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo. Cell Metabol. 2011, 14:339-351.
11. Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 2008, 183:795-803.
12. Rausch W.D., Hirata Y., Nagatsu T., Riederer P., Jellinger K. Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agents. J. Neurochem. 1988, 50:202-208.
13. Roede J.R., Jones D.P. Reactive species and mitochondrial dysfunction: mechanistic significance of 4-hydroxynonenal. Environ. Mol. Mutagen. 2010, 51:380-390.
14. Rouault T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2006, 2:406-414.
15. Sato S., Chiba T., Nishiyama S., Kakiuchi T., Tsukada H., Hatano T., Fukuda T., Yasoshima Y., Kai N., Kobayashi K., Mizuno Y., Tanaka K., Hattori N. Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography. J. Neurosci. Res. 2006, 84:1350-1357.
16. Schon E.A., Przedborski S. Mitochondria: the next (neurode) generation. Neuron 2011, 70:1033-1053.
17. Smith M.A., Harris P.L., Sayre L.M., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9866-9868.
18. Takanashi M., Mochizuki H., Yokomizo K., Hattori N., Mori H., Yamamura Y., Mizuno Y. Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP). Parkinsonism Relat. Disord. 2001, 7:311-314.
19. Tokunaga F., Sakata S., Saeki Y., Satomi Y., Kirisako T., Kamei K., Nakagawa T., Kato M., Murata S., Yamaoka S., Yamamoto M., Akira S., Takao T., Tanaka K., Iwai K. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 2009, 11:123-132.
20. Zarkovic N., Cipak A., Jaganjac M., Borovic S., Zarkovic K. Pathophysiological relevance of aldehydic protein modifications. J. Proteomics 2013, 92:239-247.
21. Zecca L., Youdim M.B., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 2004, 5:863-873.